Ospemifene Patent Expiration
Ospemifene is used for treating symptoms of urogenital atrophy, dyspareunia, and vaginal dryness associated with menopause. It was first introduced by Duchesnay Inc
Ospemifene Patents
Given below is the list of patents protecting Ospemifene, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Osphena | US6245819 | Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause | Jul 21, 2025 | Duchesnay |
| Osphena | US8236861 | Method for enhancing the bioavailablity of ospemifene | Aug 11, 2026 | Duchesnay |
| Osphena | US8470890 | Method for enhancing the bioavailability of ospemifene |
Feb 13, 2024
(Expired) | Duchesnay |
| Osphena | US8642079 | Solid formulations of ospemifene | Jul 09, 2028 | Duchesnay |
| Osphena | US8772353 | Method for enhancing the bioavalability of ospemifene |
Feb 13, 2024
(Expired) | Duchesnay |
| Osphena | US9241915 | Method for enhancing the bioavailability of ospemifene |
Feb 13, 2024
(Expired) | Duchesnay |
| Osphena | US9566252 | Method for the alleviation of dyspareunia in women |
Nov 02, 2022
(Expired) | Duchesnay |
| Osphena | US9855224 | Method for enhancing the bioavailability of ospemifene |
Feb 13, 2024
(Expired) | Duchesnay |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Ospemifene Generics
Only one generic application has been filed for Ospemifene.
Given below is the list of companies who have filed for Ospemifene generic.
1. HETERO LABS LTD V
Hetero Labs Ltd Unit V has filed for 1 generic for Ospemifene. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 60MG | tablet | Prescription | ORAL | AB | Feb 13, 2024 |